Results 131 to 140 of about 23,160 (290)

Batten's disease. [PDF]

open access: yesBritish Journal of Ophthalmology, 1980
openaire   +2 more sources

Self‐limited neonatal epilepsy with 2q24.3 duplications: Case series and literature review

open access: yesEpileptic Disorders, EarlyView.
Abstract Objective To clarify the phenotypic spectrum associated with duplications involving the 2q24.3 region, which includes a cluster of genes encoding sodium channel subunits (SCN1A, SCN2A, SCN3A, SCN7A, and SCN9A). Methods We reviewed our research database for patients with epilepsy and 2q24.3 duplication and performed thorough phenotyping.
Saba Al Rawahi, Kenneth A. Myers
wiley   +1 more source

Protracted CLN3 Batten disease in mice that genetically model an exon-skipping therapeutic approach. [PDF]

open access: yesMol Ther Nucleic Acids, 2023
Centa JL   +7 more
europepmc   +1 more source

Recent advances in multifunctional soft robots: A materials–structures–systems co‐design perspective for synergistic integration

open access: yesFlexMat, EarlyView.
Abstract Soft robots, engineered from highly compliant materials, offer superior adaptability and safety in unstructured environments compared to their rigid counterparts. Recent advancements, fueled by bio‐inspiration and material programmability, have led to the rapid co‐evolution of their core modules: actuation, sensing, protection, energy, and ...
Qiulei Liu   +3 more
wiley   +1 more source

The Batten disease protein CLN3 is important for stress granules dynamics and translational activity. [PDF]

open access: yesJ Biol Chem, 2023
Relton EL   +10 more
europepmc   +1 more source

Optimization of Multi‐Millet Cookie Formulation Using Mixture Design and Their Physicochemical Characterization

open access: yesFood Safety and Health, EarlyView.
Sensory‐driven optimization of multi‐millet cookie formulation using RSM. ABSTRACT The effect of the composition of multi‐millet flour on the sensory acceptability of gluten‐free cookies containing xanthan gum as a binding agent was investigated and optimized.
Akash Kumar   +4 more
wiley   +1 more source

Efficacy of dual intracerebroventricular and intravitreal CLN5 gene therapy in sheep prompts the first clinical trial to treat CLN5 Batten disease. [PDF]

open access: yesFront Pharmacol, 2023
Murray SJ   +8 more
europepmc   +1 more source

Gene Therapy and Battens Disease

open access: yesInternal Medicine: Open Access, 2017
Late Infantile Neuronal Ceroid Lipofuscinoses is an inherited neurodegenerative condition caused by a mutation in the CLN2 gene that codes for an enzyme, tripeptidyl peptidase I (TPP-1). Deficiencies in TPP-1 lead to protein accumulation within lysosomes and subsequent neuronal death, which produce the clinical features of the disease.
openaire   +1 more source

Magnetic resonance brain volumetry biomarkers of CLN2 Batten disease identified with miniswine model. [PDF]

open access: yesSci Rep, 2023
Knoernschild K   +8 more
europepmc   +1 more source

Postpartum anemia and maternal wellbeing: A cohort analysis of the WOMAN‐2 trial

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective We examined the association between postpartum anemia and maternal wellbeing in women who gave birth with anemia. Methods We conducted a cohort analysis using secondary data from the WOMAN‐2 trial. Between August 2019 and September 2023, women with moderate or severe anemia who were giving birth vaginally were recruited from ...
The WOMAN‐2 Trial Collaborators   +180 more
wiley   +1 more source

Home - About - Disclaimer - Privacy